SCHEMBL533116

SCHEMBL533116

Cc1ccccc1-c1ccccc1C(=O)Nc1c(C)cc(C)c(N2CCCC2)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
ALDH1A1 P00352 7/20 0.46
L3MBTL1 Q9Y468 6/20 0.46
GAA P10253 4/20 0.46
NPSR1 Q6W5P4 4/20 0.46
MAPK1 P28482 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
ATM Q13315 2/20 0.46
KMT2A Q03164 6/20 0.44
BRPF1 P55201 1/20 0.43
MEN1 O00255 3/20 0.42
LMNA P02545 2/20 0.41
TP53 P04637 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533064 0.90 MAPT (0.56) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL532826 0.90 ALDH1A1 (0.47) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL532809 0.89 ALDH1A1 (0.46) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL532902 0.88 L3MBTL1 (0.43) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL532983 0.87 MAPT (0.46) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL533307 0.86 F10 (0.43) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL533536 0.86 L3MBTL1 (0.49) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL534076 0.86 POLB (0.53) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL532801 0.85 GAA (0.48) MAPTALDH1A1L3MBTL1GAANPSR1
SCHEMBL532964 0.85 L3MBTL1 (0.47) MAPTALDH1A1L3MBTL1GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed